A Liquid Biopsy in Bladder Cancer—The Current Landscape in Urinary Biomarkers

The non-muscle invasive bladder cancer tends to recur and progress. Therefore, it requires frequent follow-ups, generating costs and making it one of the most expensive neoplasms. Considering the expensive and invasive character of the current gold-standard diagnostic procedure, white-light cystosco...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2022-08, Vol.23 (15), p.8597
Main Authors: Matuszczak, Milena, Kiljańczyk, Adam, Salagierski, Maciej
Format: Article
Language:English
Subjects:
biological fluids
Biomarkers
Biopsy
Bladder cancer
Cancer
cancer biomarkers
cell-free DNA
Cellular biology
DNA methylation
Hematuria
Invasiveness
liquid biopsy
Medical prognosis
Muscles
Neoplasms
personalized therapy
precision oncology
Prognosis
Review
Tumors
Urine
Urogenital system
White light
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c455t-a13bbdd58f9fefb6ab1e697169a13ea1ed04dea02cab9bfeb71fc3ba3bd4fe363
cites cdi_FETCH-LOGICAL-c455t-a13bbdd58f9fefb6ab1e697169a13ea1ed04dea02cab9bfeb71fc3ba3bd4fe363
container_end_page
container_issue 15
container_start_page 8597
container_title International journal of molecular sciences
container_volume 23
creator Matuszczak, Milena
Kiljańczyk, Adam
Salagierski, Maciej
description The non-muscle invasive bladder cancer tends to recur and progress. Therefore, it requires frequent follow-ups, generating costs and making it one of the most expensive neoplasms. Considering the expensive and invasive character of the current gold-standard diagnostic procedure, white-light cystoscopy, efforts to find an alternative method are ongoing. Although the last decade has seen significant advancements in urinary biomarker tests (UBTs) for bladder cancer, international guidelines have not recommended them. Currently, the paramount urgency is to find and validate the test with the best specificity and sensitivity, which would allow for the optimizing of diagnosis, prognosis, and a treatment plan. This review aims to summarise the up-to-date state of knowledge relating to UBTs and new developments in the detection, prognosis, and surveillance of bladder cancer and their potential applications in clinical practice.
doi_str_mv 10.3390/ijms23158597
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_fb4d7703a9714406a70efd32f15791c0</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_fb4d7703a9714406a70efd32f15791c0</doaj_id><sourcerecordid>2700753163</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-a13bbdd58f9fefb6ab1e697169a13ea1ed04dea02cab9bfeb71fc3ba3bd4fe363</originalsourceid><addsrcrecordid>eNpdkc1OGzEQgK2qqFDaWx9gpV56aIp_1vb6Ugki2iJF4gJna2yPwelmN9hZpNz6EH3CPglOgxBwGmvm8zdjDyGfGP0mhKEnabkqXDDZSaPfkCPWcj6jVOm3z86H5H0pS0q54NK8I4dCGik110fk8rRZpLspheYsjeuybdLQnPUQAuZmDoPH_O_P36tbbOZTzjhsmgUMoXhY4468zmmAvN3dXUH-jbl8IAcR-oIfH-Mxuf5xfjX_NVtc_ryYny5mvpVyMwMmnAtBdtFEjE6BY6iMZsrUCgLDQNuAQLkHZ1xEp1n0woFwoY0olDgmF3tvGGFp1znV_ls7QrL_E2O-sZA3yfdoo2uD1lRA9bctVaApxiB4ZFIb5ml1fd-71pNbYfD1mRn6F9KXlSHd2pvx3hqhDOu6KvjyKMjj3YRlY1epeOx7GHCciuWactYp3bKKfn6FLscpD_WrdhTVUjAlKvV1T_k8lpIxPg3DqN1t3T7fungAnXGgYQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2700753163</pqid></control><display><type>article</type><title>A Liquid Biopsy in Bladder Cancer—The Current Landscape in Urinary Biomarkers</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><creator>Matuszczak, Milena ; Kiljańczyk, Adam ; Salagierski, Maciej</creator><creatorcontrib>Matuszczak, Milena ; Kiljańczyk, Adam ; Salagierski, Maciej</creatorcontrib><description>The non-muscle invasive bladder cancer tends to recur and progress. Therefore, it requires frequent follow-ups, generating costs and making it one of the most expensive neoplasms. Considering the expensive and invasive character of the current gold-standard diagnostic procedure, white-light cystoscopy, efforts to find an alternative method are ongoing. Although the last decade has seen significant advancements in urinary biomarker tests (UBTs) for bladder cancer, international guidelines have not recommended them. Currently, the paramount urgency is to find and validate the test with the best specificity and sensitivity, which would allow for the optimizing of diagnosis, prognosis, and a treatment plan. This review aims to summarise the up-to-date state of knowledge relating to UBTs and new developments in the detection, prognosis, and surveillance of bladder cancer and their potential applications in clinical practice.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms23158597</identifier><identifier>PMID: 35955727</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>biological fluids ; Biomarkers ; Biopsy ; Bladder cancer ; Cancer ; cancer biomarkers ; cell-free DNA ; Cellular biology ; DNA methylation ; Hematuria ; Invasiveness ; liquid biopsy ; Medical prognosis ; Muscles ; Neoplasms ; personalized therapy ; precision oncology ; Prognosis ; Review ; Tumors ; Urine ; Urogenital system ; White light</subject><ispartof>International journal of molecular sciences, 2022-08, Vol.23 (15), p.8597</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-a13bbdd58f9fefb6ab1e697169a13ea1ed04dea02cab9bfeb71fc3ba3bd4fe363</citedby><cites>FETCH-LOGICAL-c455t-a13bbdd58f9fefb6ab1e697169a13ea1ed04dea02cab9bfeb71fc3ba3bd4fe363</cites><orcidid>0000-0001-8646-1219 ; 0000-0001-8050-1507</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2700753163/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2700753163?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids></links><search><creatorcontrib>Matuszczak, Milena</creatorcontrib><creatorcontrib>Kiljańczyk, Adam</creatorcontrib><creatorcontrib>Salagierski, Maciej</creatorcontrib><title>A Liquid Biopsy in Bladder Cancer—The Current Landscape in Urinary Biomarkers</title><title>International journal of molecular sciences</title><description>The non-muscle invasive bladder cancer tends to recur and progress. Therefore, it requires frequent follow-ups, generating costs and making it one of the most expensive neoplasms. Considering the expensive and invasive character of the current gold-standard diagnostic procedure, white-light cystoscopy, efforts to find an alternative method are ongoing. Although the last decade has seen significant advancements in urinary biomarker tests (UBTs) for bladder cancer, international guidelines have not recommended them. Currently, the paramount urgency is to find and validate the test with the best specificity and sensitivity, which would allow for the optimizing of diagnosis, prognosis, and a treatment plan. This review aims to summarise the up-to-date state of knowledge relating to UBTs and new developments in the detection, prognosis, and surveillance of bladder cancer and their potential applications in clinical practice.</description><subject>biological fluids</subject><subject>Biomarkers</subject><subject>Biopsy</subject><subject>Bladder cancer</subject><subject>Cancer</subject><subject>cancer biomarkers</subject><subject>cell-free DNA</subject><subject>Cellular biology</subject><subject>DNA methylation</subject><subject>Hematuria</subject><subject>Invasiveness</subject><subject>liquid biopsy</subject><subject>Medical prognosis</subject><subject>Muscles</subject><subject>Neoplasms</subject><subject>personalized therapy</subject><subject>precision oncology</subject><subject>Prognosis</subject><subject>Review</subject><subject>Tumors</subject><subject>Urine</subject><subject>Urogenital system</subject><subject>White light</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkc1OGzEQgK2qqFDaWx9gpV56aIp_1vb6Ugki2iJF4gJna2yPwelmN9hZpNz6EH3CPglOgxBwGmvm8zdjDyGfGP0mhKEnabkqXDDZSaPfkCPWcj6jVOm3z86H5H0pS0q54NK8I4dCGik110fk8rRZpLspheYsjeuybdLQnPUQAuZmDoPH_O_P36tbbOZTzjhsmgUMoXhY4468zmmAvN3dXUH-jbl8IAcR-oIfH-Mxuf5xfjX_NVtc_ryYny5mvpVyMwMmnAtBdtFEjE6BY6iMZsrUCgLDQNuAQLkHZ1xEp1n0woFwoY0olDgmF3tvGGFp1znV_ls7QrL_E2O-sZA3yfdoo2uD1lRA9bctVaApxiB4ZFIb5ml1fd-71pNbYfD1mRn6F9KXlSHd2pvx3hqhDOu6KvjyKMjj3YRlY1epeOx7GHCciuWactYp3bKKfn6FLscpD_WrdhTVUjAlKvV1T_k8lpIxPg3DqN1t3T7fungAnXGgYQ</recordid><startdate>20220801</startdate><enddate>20220801</enddate><creator>Matuszczak, Milena</creator><creator>Kiljańczyk, Adam</creator><creator>Salagierski, Maciej</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8646-1219</orcidid><orcidid>https://orcid.org/0000-0001-8050-1507</orcidid></search><sort><creationdate>20220801</creationdate><title>A Liquid Biopsy in Bladder Cancer—The Current Landscape in Urinary Biomarkers</title><author>Matuszczak, Milena ; Kiljańczyk, Adam ; Salagierski, Maciej</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-a13bbdd58f9fefb6ab1e697169a13ea1ed04dea02cab9bfeb71fc3ba3bd4fe363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>biological fluids</topic><topic>Biomarkers</topic><topic>Biopsy</topic><topic>Bladder cancer</topic><topic>Cancer</topic><topic>cancer biomarkers</topic><topic>cell-free DNA</topic><topic>Cellular biology</topic><topic>DNA methylation</topic><topic>Hematuria</topic><topic>Invasiveness</topic><topic>liquid biopsy</topic><topic>Medical prognosis</topic><topic>Muscles</topic><topic>Neoplasms</topic><topic>personalized therapy</topic><topic>precision oncology</topic><topic>Prognosis</topic><topic>Review</topic><topic>Tumors</topic><topic>Urine</topic><topic>Urogenital system</topic><topic>White light</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matuszczak, Milena</creatorcontrib><creatorcontrib>Kiljańczyk, Adam</creatorcontrib><creatorcontrib>Salagierski, Maciej</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matuszczak, Milena</au><au>Kiljańczyk, Adam</au><au>Salagierski, Maciej</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Liquid Biopsy in Bladder Cancer—The Current Landscape in Urinary Biomarkers</atitle><jtitle>International journal of molecular sciences</jtitle><date>2022-08-01</date><risdate>2022</risdate><volume>23</volume><issue>15</issue><spage>8597</spage><pages>8597-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>The non-muscle invasive bladder cancer tends to recur and progress. Therefore, it requires frequent follow-ups, generating costs and making it one of the most expensive neoplasms. Considering the expensive and invasive character of the current gold-standard diagnostic procedure, white-light cystoscopy, efforts to find an alternative method are ongoing. Although the last decade has seen significant advancements in urinary biomarker tests (UBTs) for bladder cancer, international guidelines have not recommended them. Currently, the paramount urgency is to find and validate the test with the best specificity and sensitivity, which would allow for the optimizing of diagnosis, prognosis, and a treatment plan. This review aims to summarise the up-to-date state of knowledge relating to UBTs and new developments in the detection, prognosis, and surveillance of bladder cancer and their potential applications in clinical practice.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>35955727</pmid><doi>10.3390/ijms23158597</doi><orcidid>https://orcid.org/0000-0001-8646-1219</orcidid><orcidid>https://orcid.org/0000-0001-8050-1507</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2022-08, Vol.23 (15), p.8597
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_fb4d7703a9714406a70efd32f15791c0
source Open Access: PubMed Central; Publicly Available Content Database
subjects biological fluids
Biomarkers
Biopsy
Bladder cancer
Cancer
cancer biomarkers
cell-free DNA
Cellular biology
DNA methylation
Hematuria
Invasiveness
liquid biopsy
Medical prognosis
Muscles
Neoplasms
personalized therapy
precision oncology
Prognosis
Review
Tumors
Urine
Urogenital system
White light
title A Liquid Biopsy in Bladder Cancer—The Current Landscape in Urinary Biomarkers
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T17%3A15%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Liquid%20Biopsy%20in%20Bladder%20Cancer%E2%80%94The%20Current%20Landscape%20in%20Urinary%20Biomarkers&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Matuszczak,%20Milena&rft.date=2022-08-01&rft.volume=23&rft.issue=15&rft.spage=8597&rft.pages=8597-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms23158597&rft_dat=%3Cproquest_doaj_%3E2700753163%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c455t-a13bbdd58f9fefb6ab1e697169a13ea1ed04dea02cab9bfeb71fc3ba3bd4fe363%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2700753163&rft_id=info:pmid/35955727&rfr_iscdi=true